3KF

(2S,3R,4S,4aR)-2,3,4,7-tetrahydroxy-3,4,4a,5-tetrahydro[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one

Created:	2014-09-03
Last modified:	2014-10-22

Find Related PDB Entry
1 entries where 3KF is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	4
Bond Count	38
Aromatic Bond Count	6

2D diagram of 3KF

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S,3R,4S,4aR)-2,3,4,7-tetrahydroxy-3,4,4a,5-tetrahydro[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one
Systematic Name (OpenEye OEToolkits)	(2S,3R,4S,4aR)-2,3,4,7-tetrakis(oxidanyl)-3,4,4a,5-tetrahydro-2H-[1,3]dioxolo[4,5-j]phenanthridin-6-one
Formula	C₁₄ H₁₃ N O₇
Molecular Weight	307.256
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C1NC4C(c3c1c(O)c2OCOc2c3)=CC(O)C(O)C4O
SMILES	CACTVS	3.385	O[CH]1C=C2[CH](NC(=O)c3c(O)c4OCOc4cc23)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.9.2	c1c2c(c(c3c1OCO3)O)C(=O)NC4C2=CC(C(C4O)O)O
Canonical SMILES	CACTVS	3.385	O[C@H]1C=C2[C@@H](NC(=O)c3c(O)c4OCOc4cc23)[C@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.9.2	c1c2c(c(c3c1OCO3)O)C(=O)N[C@@H]4C2=C[C@@H]([C@H]([C@H]4O)O)O
InChI	InChI	1.03	InChI=1S/C14H13NO7/c16-6-1-5-4-2-7-13(22-3-21-7)11(18)8(4)14(20)15-9(5)12(19)10(6)17/h1-2,6,9-10,12,16-19H,3H2,(H,15,20)/t6-,9+,10+,12-/m0/s1
InChIKey	InChI	1.03	LZAZURSABQIKGB-AEKGRLRDSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL98745
PubChem	72376
ChEMBL	CHEMBL98745
ChEBI	CHEBI:70169
CCDC/CSD	NEQGUN
COD	2237213

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.